Drug Shortage Report for APO-TIMOP

Last updated on 2021-12-13 History
Report ID 130810
Drug Identification Number 00755834
Brand name APO-TIMOP
Common or Proper name TIMOLOL OPTHALMIC
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) TIMOLOL
Strength(s) 0.5%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10 ML
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-11-15
Actual start date 2021-10-27
Estimated end date 2021-12-10
Actual end date 2021-12-10
Shortage status Resolved
Updated date 2021-12-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-01-04 English Compare
v2 2021-01-04 French Compare
v3 2021-06-01 English Compare
v4 2021-06-01 French Compare
v5 2021-07-31 English Compare
v6 2021-08-17 English Compare
v7 2021-08-17 French Compare
v8 2021-09-04 English Compare
v9 2021-09-17 English Compare
v10 2021-09-17 French Compare
v11 2021-10-16 English Compare
v12 2021-10-18 English Compare
v13 2021-10-18 French Compare
v14 2021-10-18 English Compare
v15 2021-10-18 French Compare
v16 2021-10-27 English Compare
v17 2021-10-27 French Compare
v18 2021-10-28 English Compare
v19 2021-10-28 English Compare
v20 2021-10-28 French Compare

Showing 1 to 20 of 23